Swiss Healthtech Stock News

Valiant Holding AG reported first-quarter 2026 results with net interest income of CHF 100.64 million and net income of CHF 33.24 million, both slightly higher than a year earlier. Despite this modest improvement, investors focused on the bank’s elevated debt levels and challenging revenue trends, which raised concerns about its financial flexibility and resilience. We’ll now examine how these weaker-than-expected earnings, alongside concerns over the high debt-to-equity ratio, shape Valiant...

Why Kuros Biosciences (SWX:KURN) is on investors’ radar today Kuros Biosciences (SWX:KURN) has drawn attention after recent share price pressure, with the stock showing a 15.1% decline over the past month and a 20.2% decline over the past 3 months. See our latest analysis for Kuros Biosciences. At the latest share price of CHF20.12, Kuros Biosciences shows weaker short term momentum, with a 1 month share price return of 15.1% decline and a year to date share price return of 24.6% decline,...

Novartis has started construction on a new radioligand therapy manufacturing facility in Denton, Texas. The Denton site expands the company’s US network for advanced cancer treatments and is part of a broader multi year, multi billion dollar US investment plan. The project is expected to support access to personalized cancer therapies and create jobs in bioengineering and advanced manufacturing. For investors following Novartis (SWX:NOVN), the Denton build out comes as the stock trades...

If you are asking whether UBS Group is priced attractively right now, the starting point is to look closely at what the current share price might already be assuming. The stock last closed at CHF 35.03, with returns of 1.5% over 7 days, 8.1% over 30 days, a 8.2% decline year to date, and gains of 38.4% over 1 year, 120.8% over 3 years and 189.1% over 5 years. Recent headlines have focused on UBS Group's role as a major global banking and wealth management group, including its ongoing...

If you are wondering whether Temenos is priced fairly or if the current share price leaves room for upside, it helps to start by looking closely at what the market has been paying for this stock recently. Temenos shares recently closed at CHF 74.20, with returns of 0.4% over 7 days, 2.3% over 30 days, a 9.0% decline year to date, and 22.6% over the past year. Together, these figures present a mixed picture of changing expectations and risk perception. Recent coverage of Temenos has focused...

If you are wondering whether Alcon at around $49.17 is starting to look like value after a tough spell, this breakdown will help you frame the opportunity and the risks. The stock has faced sharp share price pressure, with returns of a 15.5% decline over 7 days, a 19.7% decline over 30 days, a 22.6% decline year to date and a 37.9% decline over 1 year, as well as a 29.9% decline over 3 years and a 19.2% decline over 5 years. Recent coverage has focused on how this sustained weakness has put...

Vaudoise Assurances Holding SA ( VTX:VAHN ) is about to trade ex-dividend in the next 3 days. The ex-dividend date is...

The investors in ams-OSRAM AG 's ( VTX:AMS ) will be rubbing their hands together with glee today, after the share...

Swiss Re (SWX:SREN) has wrapped up FY 2025 with fourth quarter revenue of US$10.6b and basic EPS of US$2.43, capping a trailing twelve month EPS of US$15.67 on total revenue of US$42.6b. Over recent quarters the company has seen revenue in a tight band between US$10.5b and US$11.0b, while quarterly EPS ranged from US$0.35 in Q3 2024 to US$4.85 in Q3 2025, giving investors a clear view of how earnings have tracked through the year. With net profit margins over the last twelve months at 10.8%...

ABB is expanding its role in digital twin technology for the marine industry, focusing on real time optimization and asset monitoring. The company is deepening its digital solutions offering for ship operators, adding to its traditional electrification and automation capabilities. This move highlights ABB's push into asset lifecycle management within a growing segment of the maritime market. For investors tracking SWX:ABBN, this push into marine digital twins sits alongside a share price of...

UBS Group is signaling interest in expanding in the US through acquisitions following its integration of Credit Suisse. Leadership is highlighting growth ambitions in the Americas and pointing to recent inflows of new client assets in the region. The group has received a national US banking license and announced executive hires in key US regions to support potential expansion. UBS Group (SWX:UBSG) is trading around CHF34.94, with the stock up 39.1% over the past year and 190.3% over five...

Investors in Logitech International S.A. ( VTX:LOGN ) had a good week, as its shares rose 6.6% to close at CHF81.82...

As you might know, Geberit AG ( VTX:GEBN ) recently reported its quarterly numbers. Geberit reported in line with...

Earnings miss, weaker profit, and new buyback sharpen focus on Alcon stock Alcon (SWX:ALC) reported first quarter 2026 revenue growth supported by recent product launches and market share gains. Profit came under pressure, guidance was reaffirmed, and a US$1.5b share repurchase plan was introduced. See our latest analysis for Alcon. Alcon's latest earnings and the new US$1.5b buyback have coincided with a sharp reset in sentiment, with a 7 day share price return of a 13.6% decline and a 1...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Sunrise Communications AG ( VTX:SUNN ) stock is about to trade ex-dividend in three days. The ex-dividend date is...

Why Logitech International (SWX:LOGN) is on investors’ radar today Logitech International (SWX:LOGN) has drawn interest after recent price moves, including a 1 day return of about a 0.4% decline and gains of roughly 3.6% over the past week and 8.9% over the past month. See our latest analysis for Logitech International. Looking beyond the latest move, Logitech’s 15.1% 90 day share price return and 27.8% 1 year total shareholder return point to momentum that contrasts with a relatively flat...

Alcon (SWX:ALC) opened 2026 with Q1 revenue of US$2.7b and basic EPS of US$0.39, setting a clear marker for how the year is starting after a period where trailing 12 month revenue sat at US$10.6b and EPS at US$1.67. Over recent quarters, the company has seen revenue move from US$2.5b in Q4 2024 to around US$2.7b in Q1 2026, while quarterly EPS has ranged from US$0.36 to US$0.71. This gives investors a wide set of earnings outcomes to weigh against a reported trailing net margin of 7.7% and...

Investors may be wondering if Novartis at CHF113.54 is still offering value, or if most of the easy gains are already on the table. The stock is up 25.9% over the last year and 41.9% over 3 years, even though it shows a 1% decline over 7 days, a 7.8% decline over 30 days, and a 4.6% return year to date. Recent headlines have focused on Novartis as a large global pharmaceutical business, with investors watching how its product portfolio and pipeline shape long term expectations. This context...

Temenos (SWX:TEMN) has secured new SaaS core banking agreements with First Abu Dhabi Bank in Saudi Arabia and Questrade in Canada. The company is expanding its SaaS offering on Amazon Web Services to cover end to end digital banking and payments. These updates relate to Temenos' cloud banking platform and its global client reach across the Middle East and North America. For Temenos, a provider of core banking and digital banking software, these wins highlight how large banks and non bank...

Bachem Holding (SWX:BANB) is back in focus after announcing the departure of Chief Commercial Officer Torsten Wöhr. CEO Anne-Kathrin Stoller is set to temporarily assume commercial responsibilities from May 25, 2026. See our latest analysis for Bachem Holding. The leadership change comes as Bachem Holding’s share price trades at CHF75.45, with a 7 day share price return of 10.71% and a year to date share price return of 29.08%. The 1 year total shareholder return of 54.39% contrasts with a 3...

Temenos (SWX:TEMN) has just paired a first quarter earnings update with a change in its finance leadership, providing fresh information on both its recent financial performance and how the company is organizing for future execution. See our latest analysis for Temenos. At a share price of CHF75.0, the stock has recovered from a softer start to the year, with a 90 day share price return of 16.64% and a 1 year total shareholder return of 27.33%. This suggests that recent momentum has been...

What Idorsia’s new QUVIVIQ guidance tells you Idorsia (SWX:IDIA) has put QUVIVIQ at the center of its 2026 outlook, guiding for CHF 200 million in sales after releasing its first quarter results and updating progress on its broader pipeline and partnerships. See our latest analysis for Idorsia. Following the first quarter update and QUVIVIQ guidance, Idorsia’s recent share price moves look mixed, with a 30 day share price return of 8.16% but a year to date share price return of a 6.35%...

Roche Holding stock: recent move puts long term returns in context Roche Holding (SWX:ROP) has drawn attention after a recent pullback, with the stock down about 0.6% over the past day and just over 1% over the past week. For readers tracking longer horizons, the share price shows a small decline over the past month and a larger negative move over the past 3 months, while multi year total returns remain positive. See our latest analysis for Roche Holding. At a share price of CHF316.5, Roche...